Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35202999)
Watch
English
Treatment of ovarian cancer: new strategies
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of ovarian cancer: new strategies
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
author
Phillip J. DiSaia
series ordinal
1
object named as
Philip J DiSaia
0 references
author name string
Jeffrey D Bloss
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
language of work or name
English
0 references
publication date
1 August 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
published in
Gynecologic Oncology
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
volume
90
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
issue
2 Pt 2
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
page(s)
S24-32
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
cites work
Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial sequencing and analysis of the human genome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacogenetics and the practice of medicine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of human ovarian carcinoma cell proliferation by liposome-plasmid DNA complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adenovirus-based p53 gene therapy in ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adenoviral-mediated suicide gene therapy for ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Angiogenesis in cancer, vascular, rheumatoid and other disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Angiozyme: a novel angiogenesis inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900341-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-8258(03)00341-X
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
PubMed ID
12928003
1 reference
stated in
Europe PubMed Central
PubMed ID
12928003
retrieved
7 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
